Evaluation of anti-diabetic activity of Trianthema portulacastrum Linn in Dithizone induced diabetes in Wistar rats

Abstract

Trianthema portulacastrum Linn. Whole plant is an extensively used plant for medication in India for the treatment of various health issues. This study was focused to prefigure the antidiabetic potency of Chloroform extract of the Trianthema portulacastrum (CETP) whole plant administered at two doses (100mg/kg and 200 mg/kg) for the duration of 21days in Dithizone induced diabetic rats. The rats were separated into five groups, each group containing six animals. All Groups except Group I were made diabetic by intraperitonial administration of Dithizone(50mg/kg). Group I served as control group, Group II served as diabetic control received Dithizone(50mg/kg), Group III rats were administered with glibenclamide (10mg/kg), a standard oral hypoglycemic agent while Group IV and Group V diabetic rats were served with 100 mg/kg and 200 mg/kg of CETP whole plant respectively. Potency of the plant extract as an antidiabetic was assessed in dithizone induced diabetic models by comparing biochemical parameters like blood glucose level, Glucose tolerance, lipid profiles along with the liver antioxidant enzymes, glycogen content and Glycogenic enzymes which were quantified using standard experimental procedures. There exists a significant reduction in levels of blood glucose, raise in glucose tolerance, and improved imbalance in lipid metabolism in diabetic rats after administration of the extract at 100mg/kg and 200mg/kg. T.portulacastrum with 200mg/kg of the extract showed the best hypoglycemic action by comparing favorably well with Glibenclamide. This investigation clearly showed that, the extract is endowed with hypoglycemic activity, T.portulacastrum may also defend the deterioration of liver due to diabetes.